Literature DB >> 4038519

Smith-McGuckin spot.

C W Smith.   

Abstract

Direct inspection of the tympanic membrane, especially with the help of the microscope, continues to be an important part of the examination of the patient suffering from ear disease. Accurate assessment of the varied appearances can be helpful in anticipating the prognosis in SMOM and may give information about the pathology of CSOM and cholesteatoma. The Smith-McGuckin spot was first described 20 years ago (Smith 1964, R Thomas 1965, personal communication) and its significance is reviewed. Further evidence of the relationship between skeletal disorders such as Turner's syndrome and persistent SMOM is described. It is suggested that bone resorption in the deep meatus, outer attic wall and ossicles may result from chronic hyperaemia rather than sepsis or avascular necrosis. The part played by cholesteatoma in bone erosion is questioned.

Entities:  

Mesh:

Year:  1985        PMID: 4038519      PMCID: PMC1289540          DOI: 10.1177/014107688507800105

Source DB:  PubMed          Journal:  J R Soc Med        ISSN: 0141-0768            Impact factor:   18.000


  6 in total

1.  THE DEVELOPMENT OF THE MIDDLE EAR SPACES AND THEIR SURGICAL SIGNIFICANCE.

Authors:  B PROCTOR
Journal:  J Laryngol Otol       Date:  1964-07       Impact factor: 1.469

2.  Deafness associated with cleft palate.

Authors:  C A HOLBOROW
Journal:  J Laryngol Otol       Date:  1962-10       Impact factor: 1.469

3.  Ear disease and hearing loss among the Eskimo population of the Baffin Zone.

Authors:  J D Baxter; D Ling
Journal:  Can J Otolaryngol       Date:  1974

4.  Tomographic and surgical pathology of cholesteatoma.

Authors:  R A Buckingham; G E Valvassori
Journal:  Arch Otolaryngol       Date:  1970-05

5.  Cholesterol in cholesteatoma and in the otitis media syndrome.

Authors:  J Sadé; A Teitz
Journal:  Am J Otol       Date:  1982-01

6.  Pathogenesis of attic cholesteatomas.

Authors:  J Sadé
Journal:  J R Soc Med       Date:  1978-10       Impact factor: 18.000

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.